Kissei Pharmaceutical Co., Ltd. (4547) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

O'will Corp.

CB GROUP MANAGEMENT Co., Ltd.

Morishita Jintan Co., Ltd.

Kissei Pharmaceutical Co., Ltd.

Astena Holdings Co., Ltd.

NANO MRNA Co., Ltd.

Yomeishu Seizo Co., Ltd.

euglena Co., Ltd.

Ohki Health Care Holdings, Inc.

Pharma Foods International Co., Ltd.

CellSeed, Inc.

Why is Kissei Pharmaceutical Co., Ltd. ?

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 89.25

Low Debt Company with Strong Long Term Fundamental Strength

Flat results in Dec 25

INTEREST(HY) At JPY 14 MM has Grown at 27.27%
RAW MATERIAL COST(Y) Grown by 9.29% (YoY)
PRE-TAX PROFIT(Q) Fallen at -38.28%

With ROE of 6.96%, it has a very attractive valuation with a 0.96 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 20.26%, its profits have risen by 31.7% ; the PEG ratio of the company is 0.4
At the current price, the company has a high dividend yield of 0

Underperformed the market in the last 1 year

The stock has generated a return of 20.26% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 36.73%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Kissei Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Kissei Pharmaceutical Co., Ltd. for you?

Low Risk, High Return

Absolute

Risk Adjusted

Volatility

Kissei Pharmaceutical Co., Ltd.

19.02%

723.64

24.51%

Japan Nikkei 225

36.73%

1.30

28.24%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.91%

EBIT Growth (5y)

25.47%

EBIT to Interest (avg)

89.25

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.23

Sales to Capital Employed (avg)

0.38

Tax Ratio

23.28%

Dividend Payout Ratio

36.47%

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

1.34%

ROE (avg)

5.25%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.96

EV to EBIT

26.65

EV to EBITDA

14.81

EV to Capital Employed

0.95

EV to Sales

1.74

PEG Ratio

0.39

Dividend Yield

0.01%

ROCE (Latest)

3.57%

ROE (Latest)

6.96%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

ROCE(HY)

Highest at 6.63%

CASH AND EQV(HY)

Highest at JPY 108,429 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 1.85 times

NET SALES(Q)

Highest at JPY 26,802 MM

OPERATING PROFIT(Q)

Highest at JPY 4,351 MM

OPERATING PROFIT MARGIN(Q)

Highest at 16.23 %

-11What is not working for the Company

INTEREST(HY)

At JPY 14 MM has Grown at 27.27%

RAW MATERIAL COST(Y)

Grown by 9.29% (YoY

PRE-TAX PROFIT(Q)

Fallen at -38.28%

NET PROFIT(Q)

Fallen at -41.62%

Here's what is working for Kissei Pharmaceutical Co., Ltd.

Net Sales

Highest at JPY 26,802 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (JPY MM)

Operating Profit

Highest at JPY 4,351 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (JPY MM)

Operating Profit Margin

Highest at 16.23 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Cash and Eqv

Highest at JPY 108,429 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio

Highest at 1.85 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Depreciation

Highest at JPY 1,196 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Kissei Pharmaceutical Co., Ltd.

Interest

At JPY 14 MM has Grown at 27.27%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Pre-Tax Profit

Fallen at -38.28%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit

Fallen at -41.62%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (JPY MM)

Raw Material Cost

Grown by 9.29% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales